94 related articles for article (PubMed ID: 3588319)
1. Advances in 99mTc-labeling of antibodies.
Fritzberg AR
Nuklearmedizin; 1987 Feb; 26(1):7-12. PubMed ID: 3588319
[TBL] [Abstract][Full Text] [Related]
2. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.
Fritzberg AR; Abrams PG; Beaumier PL; Kasina S; Morgan AC; Rao TN; Reno JM; Sanderson JA; Srinivasan A; Wilbur DS
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4025-9. PubMed ID: 3375252
[TBL] [Abstract][Full Text] [Related]
3. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m labeling of murine monoclonal antibody fragments.
Rhodes BA; Zamora PO; Newell KD; Valdez EF
J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
[TBL] [Abstract][Full Text] [Related]
5. Site-specific 99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain.
Jeong JM; Lee J; Paik CH; Kim DK; Lee DS; Chung JK; Lee MC
Arch Pharm Res; 2004 Sep; 27(9):961-7. PubMed ID: 15473668
[TBL] [Abstract][Full Text] [Related]
6. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method.
Pak KY; Nedelman MA; Tam SH; Wilson E; Daddona PE
Int J Rad Appl Instrum B; 1992 Aug; 19(6):669-77. PubMed ID: 1522021
[TBL] [Abstract][Full Text] [Related]
7. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
Garron JY; Moinereau M; Pasqualini R; Saccavini JC
Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
[TBL] [Abstract][Full Text] [Related]
8. Direct labeling of proteins with 99mTc.
Rhodes BA
Int J Rad Appl Instrum B; 1991; 18(7):667-76. PubMed ID: 1787075
[TBL] [Abstract][Full Text] [Related]
9. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
10. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
Baidoo KE; Scheffel U; Lever SZ
Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
13. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.
Childs RL; Hnatowich DJ
J Nucl Med; 1985 Mar; 26(3):293-9. PubMed ID: 3882905
[TBL] [Abstract][Full Text] [Related]
14. Serum stability and non-specific binding of technetium-99m labeled diaminodithiol for protein labeling.
Liang FH; Virzi F; Hnatowich DJ
Int J Rad Appl Instrum B; 1987; 14(6):555-61. PubMed ID: 3429236
[TBL] [Abstract][Full Text] [Related]
15. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.
Misri R; Saatchi K; Häfeli UO
Nucl Med Commun; 2011 Apr; 32(4):324-9. PubMed ID: 21285909
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites.
John E; Thakur ML; Wilder S; Alauddin MM; Epstein AL
J Nucl Med; 1994 May; 35(5):876-81. PubMed ID: 8176476
[TBL] [Abstract][Full Text] [Related]
20. Development of radiochemically pure antibodies.
Eckelman WC
Cancer Res; 1990 Feb; 50(3 Suppl):780s-782s. PubMed ID: 2297723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
